Dermata Therapeutics Correlations

DRMA Stock

USD 1.13 0.04 3.67%

The current 90-days correlation between Dermata Therapeutics and Phio Pharmaceuticals Corp is 0.01 (i.e., Significant diversification). The correlation of Dermata Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Dermata Therapeutics Correlation With Market

Average diversification

The correlation between Dermata Therapeutics and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dermata Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Dermata Stock refer to our How to Trade Dermata Stock guide.

Moving together with Dermata Stock

0.62	VALN	Valneva SE ADR	Pair Corr
0.63	ERNA	Eterna Therapeutics	Pair Corr
0.71	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.67	LLY	Eli Lilly	Pair Corr
0.8	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.69	PFE	Pfizer Inc Fiscal Year End 4th of February 2025	Pair Corr
0.69	INBX	Inhibrx Symbol Change	Pair Corr
0.66	SXTPW	60 Degrees Pharmaceu	Pair Corr
0.71	MRVI	Maravai Lifesciences	Pair Corr
0.79	REGN	Regeneron Pharmaceuticals	Pair Corr
0.74	AKAN	Akanda Corp	Pair Corr
0.66	AMGN	Amgen Inc	Pair Corr
0.66	ANRO	Alto Neuroscience,	Pair Corr
0.7	SMMT	Summit Therapeutics PLC	Pair Corr

Moving against Dermata Stock

0.73	BMY	Bristol Myers Squibb	Pair Corr
0.57	GILD	Gilead Sciences	Pair Corr
0.48	ESPR	Esperion Therapeutics	Pair Corr
0.31	DYAI	Dyadic International	Pair Corr
0.44	MNMD	Mind Medicine	Pair Corr
0.4	ALVO	Alvotech	Pair Corr
0.68	TARS	Tarsus Pharmaceuticals	Pair Corr

Related Correlations Analysis

	ZURA	PHIO	SONN	ATNF	CDIO	WINT	ENSC	PBLA	BXRX	ZVSA
ZURA		0.41	0.62	0.49	-0.5	0.21	-0.27	0.46	-0.28	0.7	ZURA
PHIO	0.41		0.7	0.02	-0.13	0.69	-0.4	0.66	0.22	0.63	PHIO
SONN	0.62	0.7		0.02	-0.46	0.83	-0.61	0.89	0.32	0.87	SONN
ATNF	0.49	0.02	0.02		-0.1	-0.3	0.19	-0.23	-0.33	0.05	ATNF
CDIO	-0.5	-0.13	-0.46	-0.1		-0.23	0.2	-0.38	0.03	-0.45	CDIO
WINT	0.21	0.69	0.83	-0.3	-0.23		-0.44	0.81	0.6	0.61	WINT
ENSC	-0.27	-0.4	-0.61	0.19	0.2	-0.44		-0.78	-0.14	-0.7	ENSC
PBLA	0.46	0.66	0.89	-0.23	-0.38	0.81	-0.78		0.35	0.89	PBLA
BXRX	-0.28	0.22	0.32	-0.33	0.03	0.6	-0.14	0.35		0.19	BXRX
ZVSA	0.7	0.63	0.87	0.05	-0.45	0.61	-0.7	0.89	0.19		ZVSA
	ZURA	PHIO	SONN	ATNF	CDIO	WINT	ENSC	PBLA	BXRX	ZVSA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

PBLA	+ 0.89	SONN
ZVSA	+ 0.89	PBLA
ZVSA	+ 0.87	SONN
WINT	+ 0.83	SONN
PBLA	+ 0.81	WINT
ZVSA	+ 0.7	ZURA

High negative correlations

PBLA	- 0.78	ENSC
ZVSA	- 0.7	ENSC
ENSC	- 0.61	SONN
CDIO	- 0.5	ZURA
CDIO	- 0.46	SONN
ZVSA	- 0.45	CDIO

Risk-Adjusted Indicators

There is a big difference between Dermata Stock performing well and Dermata Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Dermata Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ZURA	4.10	(0.82)	0.00	(0.23)	0.00	0.00	7.95	(9.71)	26.70
PHIO	4.77	0.15	0.02	0.28	5.69	(5.66)	11.78	(9.23)	36.22
SONN	5.28	(1.67)	0.00	16.91	0.00	0.00	13.38	(15.35)	37.58
ATNF	12.01	2.46	0.37	0.46	6.95	(21.37)	14.14	(11.29)	358.73
CDIO	9.66	2.85	0.32	1.75	6.61	(16.89)	40.74	(12.90)	57.04
WINT	6.40	(2.72)	0.00	(115.67)	0.00	0.00	9.58	(18.48)	63.85
ENSC	11.24	2.04	0.19	(2.85)	9.25	(16.75)	24.85	(16.67)	189.26
PBLA	7.11	(2.15)	0.00	1.71	0.00	0.00	10.70	(17.30)	88.58
BXRX	6.57	(0.20)	0.00	0.23	0.00	0.00	8.24	(15.31)	141.24
ZVSA	3.83	(1.36)	0.00	(0.25)	0.00	0.00	7.55	(7.89)	78.93

Dermata Therapeutics Corporate Management

Maria MBA	Senior Assurance	Profile
Gerald Proehl	President, Founder	Profile
Sean Proehl	Senior Development	Profile
David Hale	CoFounder Director	Profile
Dr MPH	Senior Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC